David is a Senior Scientist in Protein Engineering at Merck, he has worked with bispecific antibodies in various formats for multiple therapeutic areas over the last 5 years. Before joining Merck he received his Master’s degree in Biochemistry and Structural Biology from Cornell University, where he worked on structural studies for receptor tyrosine kinases
Anti-CD3 antibody screening platform for TCE potency
Automation platform for bispecific antibody assembly
TCE potency decoupled from T-cell binding